Homocysteine, pharmacogenetics, methotrexate exposure and toxicity in children with acute lymphoblastic leukemia.

被引：0
|
作者：
Kishi, S
Griener, J
Cheng, C
Das, S
Cook, EH
Pei, DQ
Hudson, M
Rubnitz, J
Sandlund, JT
Pui, CH
Relling, MV
机构：
[1] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
[2] Texas Tech Sch Pharm, Amarillo, TX USA
[3] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3008
引用
收藏
页码：760A / 760A
页数：1
相关论文
共 50 条
  • [41] METHOTREXATE-INDUCED MALABSORPTION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    CRAFT, AW
    KAY, HEM
    LAWSON, DN
    MCELWAIN, TJ
    BRITISH MEDICAL JOURNAL, 1977, 2 (6101): : 1511 - 1512
  • [42] Thrombosis in children with acute lymphoblastic leukemia. Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and therapy
    Athale, UH
    Chan, AKC
    THROMBOSIS RESEARCH, 2003, 111 (4-5) : 199 - 212
  • [43] Rearranged Infant Acute Lymphoblastic Leukemia.
    Stam, Ronald W.
    Den Boer, Monique L.
    Schneider, Pauline
    de Boer, Jasper
    Hagelstein, Jill
    Sallan, Stephen E.
    Brady, Hugh J. M.
    Armstrong, Scott
    Pieters, Rob
    BLOOD, 2008, 112 (11) : 668 - 668
  • [44] Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia
    EL-Khodary, Noha M.
    EL-Haggar, Sahar M.
    Eid, Manal A.
    Ebeid, Emad N.
    MEDICAL ONCOLOGY, 2012, 29 (03) : 2053 - 2062
  • [45] Acute lymphoblastic leukemia at relapse in an adult with acute myeloid leukemia.
    Lounici, A
    ConyMakhoul, P
    Lacombe, F
    Boiron, JM
    Merlio, JP
    Marit, G
    Reiffers, J
    BLOOD, 1996, 88 (10) : 3391 - 3391
  • [46] Severe central nervous system toxicity as a result of systemic and intrathecal methotrexate is children with acute lymphoblastic leukemia
    Verrips, AA
    Camaro, CC
    Bökkerink, JJ
    Hekster, CY
    NEUROLOGY, 2001, 56 (08) : A252 - A253
  • [47] Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia
    Csordas, Katalin
    Hegyi, Marta
    Eipel, Oliver T.
    Muller, Judit
    Erdelyi, Daniel J.
    Kovacs, Gabor T.
    ANTI-CANCER DRUGS, 2013, 24 (02) : 189 - 197
  • [48] Medium and high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia (ALL)
    Hedavatiasl, Amirabas
    Darbandi, Bahram
    Vossough, Parvaneh
    Faranoush, Mohammad
    Golpayegani, Mohammad Reza
    Zangooie, Rokhsaneh
    Yazdi, Fatemeh
    Rafsanjani, Khadijeh Arjmandi
    Ansari, Shahla
    Zarrabi, Mohammad
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 490 - 491
  • [49] Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia
    Noha M. EL-Khodary
    Sahar M. EL-Haggar
    Manal A. Eid
    Emad N. Ebeid
    Medical Oncology, 2012, 29 : 2053 - 2062
  • [50] Disparities in pegasparagase-induced toxicity in Hispanic patients with acute lymphoblastic leukemia.
    Boulter, Alexis Chen
    Sovich, Justin Lin
    Kainthla, Radhika
    Sadeghi, Navid
    Jones, Amy Little
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18590 - E18590
12345